Could cause temporary or reversible harm; serious harm is unlikely.
Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.
| Brand name | ATENOLOL |
| Generic name | ATENOLOL |
| Active ingredient(s) | ATENOLOL |
| Distributed by / for | Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA |
| NDC | 68382-022-01 |
| Full product label | ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01 |
| Recalling firm | Zydus Pharmaceuticals USA Inc |
| Distribution | Nationwide |
| Quantity | 5400 bottles |
| Recall initiated | 2014-08-05 |
| Report date | 2014-10-15 |
| Recall completed | 2017-09-22 |
| Recall number | D-0007-2015 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗